Ataraxis AI: $20.4 Million (Series A) Raised For Transforming Precision Medicine In Cancer Care

Ataraxis AI Raises $20.4 Million in Series A Led by AIX Ventures

Ataraxis AI to Transform Precision Medicine in Cancer Care with $20.4 Million Series A

#NYCtech Week in Review: 1/5/25 – 1/11/25

Oncology Specialist

Ataraxis AI is an AI precision medicine company focused on revolutionizing oncology treatments through advanced AI tools. They are seeking an Oncology Specialist to drive sales growth and market penetration of their oncology products by engaging directly with oncologists in Texas.

Sign up with Google

Sign in with Google